Search
It’s not every day that scientists discover a new part of the cell. Two biologists from the Sloan Kettering Institute just did.
The word “epigenetic” literally means “above the genes.” Calico cats demonstrate a type of epigenetic inheritance called X-inactivation.
Memorial Sloan Kettering Cancer Center (MSK) today announced the establishment of The Starr Foundation Program for Discovery Science, a pioneering new initiative made possible by a generous $50 million gift from The Starr Foundation. The program will support the visionary work of scientists at the Sloan Kettering Institute (SKI), the research arm of MSK, by funding foundational laboratory research that will drive the next generation of cancer breakthroughs and ultimately improve the lives of people facing cancer around the world.
Human data and results from mouse experiments suggest that people with BRCA2 mutations may respond well to immunotherapy drugs.
In mice, drugs that change the way proteins are assembled appear to make checkpoint inhibitor drugs work better.
Scientists have long known that cancer cells and immune cells have an uncommon hunger for glucose but haven’t understood why. A new study offers an answer.
The revised scoring system incorporates molecular information related to 31 genes to help predict risk.
Dr. Maciejowski studies chromosome instability and its role in cancer. In a May 2021 interview, he discussed how he got into science and what his lab has been focusing on lately.
GSK’s Fourth Biennial Retreat on May 6 and 7 at the Mohonk Mountain House in New Paltz, New York, will feature former Sloan Kettering Institute Director Dr. Thomas J. Kelly.
Developmental biologist Maria Jasin studies homologous recombination, which is important in DNA repair and can lead to cancer when it malfunctions.